Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Pulmonary Hypertension

  Free Subscription


18.04.2017

1 Ann Thorac Surg
1 Basic Res Cardiol
1 BMC Pulm Med
1 Br J Pharmacol
3 Cardiovasc Res
1 Circ Heart Fail
1 Clin Appl Thromb Hemost
1 Clin Investig Arterioscler
3 Clin Rheumatol
1 Cytotherapy
1 Eur J Radiol
9 Eur Respir Rev
1 FEBS Open Bio
1 G Ital Cardiol (Rome)
1 Heart Vessels
2 Histol Histopathol
1 Int Immunopharmacol
1 Intern Med
1 J Coll Physicians Surg Pak
1 J Int Med Res
2 J Pediatr Surg
1 Oncotarget
1 Paediatr Drugs
1 Pneumonol Alergol Pol
1 Poult Sci
1 Rev Chil Pediatr
1 Rev Esp Cardiol (Engl Ed)
1 World J Gastroenterol
1 Zhongguo Dang Dai Er Ke Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Thorac Surg

  1. PATEL HJ, Likosky DS, Pruitt AL, Murphy ET, et al
    Aortic Valve Replacement in the Moderately Elevated Risk Patient: A Population-Based Analysis of Outcomes.
    Ann Thorac Surg. 2016 Jun 18. pii: S0003-4975(16)30368.
    PubMed     Text format     Abstract available


    Basic Res Cardiol

  2. SCHUOLER C, Haider TJ, Leuenberger C, Vogel J, et al
    Aquaporin 1 controls the functional phenotype of pulmonary smooth muscle cells in hypoxia-induced pulmonary hypertension.
    Basic Res Cardiol. 2017;112:30.
    PubMed     Text format     Abstract available


    BMC Pulm Med

  3. HERESI GA, Platt DM, Wang W, Divers CH, et al
    Healthcare burden of pulmonary hypertension owing to lung disease and/or hypoxia.
    BMC Pulm Med. 2017;17:58.
    PubMed     Text format     Abstract available


    Br J Pharmacol


  4. Retracted: Mice lacking the Raf-1 kinase inhibitor protein exhibit exaggerated hypoxia-induced pulmonary hypertension, by I Morecroft, B Doyle, M Nilsen, W Kolch, K Mair and MR MacLean. British Journal of Pharmacology, volume 163(5): 948-963, publishe
    Br J Pharmacol. 2017;174:911.
    PubMed     Text format     Abstract available


    Cardiovasc Res

  5. MERKUS D, Schermuly RT
    Farnesylation of RhoB: the cancer hypothesis of pulmonary hypertension revisited.
    Cardiovasc Res. 2017;113:249-250.
    PubMed     Text format    

  6. DULUC L, Ahmetaj-Shala B, Mitchell J, Abdul-Salam VB, et al
    Tipifarnib prevents development of hypoxia-induced pulmonary hypertension.
    Cardiovasc Res. 2017;113:276-287.
    PubMed     Text format     Abstract available

  7. JIA D, He Y, Zhu Q, Liu H, et al
    RAGE-mediated extracellular matrix proteins accumulation exacerbates HySu-induced pulmonary hypertension.
    Cardiovasc Res. 2017 Apr 11. doi: 10.1093.
    PubMed     Text format     Abstract available


    Circ Heart Fail

  8. COVELLA M, Rowin EJ, Hill NS, Preston IR, et al
    Mechanism of Progressive Heart Failure and Significance of Pulmonary Hypertension in Obstructive Hypertrophic Cardiomyopathy.
    Circ Heart Fail. 2017;10:e003689.
    PubMed     Text format     Abstract available


    Clin Appl Thromb Hemost

  9. AKBAY NO, Bingol Z, Kiyan E, Karaayvaz EB, et al
    Fractional Exhaled Nitric Oxide Measurement in Pulmonary Hypertension: A Follow-Up Study.
    Clin Appl Thromb Hemost. 2017 Jan 1:1076029617702243.
    PubMed     Text format     Abstract available


    Clin Investig Arterioscler

  10. BONAFEDE RJ, Calvo JP, Fausti JM, Puebla S, et al
    Nitric oxide: A new possible biomarker in heart failure? Relationship with pulmonary hypertension secondary to left heart failure.
    Clin Investig Arterioscler. 2017 Apr 5. pii: S0214-9168(17)30016.
    PubMed     Text format     Abstract available


    Clin Rheumatol

  11. ILGEN U, Yayla ME, Duzgun N
    Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis.
    Clin Rheumatol. 2017;36:367-372.
    PubMed     Text format     Abstract available

  12. MICHELFELDER M, Becker M, Riedlinger A, Siegert E, et al
    Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
    Clin Rheumatol. 2017;36:381-390.
    PubMed     Text format     Abstract available

  13. ITO T, Tamura N, Okuda S, Tada K, et al
    Elevated serum levels of soluble CD146 in patients with systemic sclerosis.
    Clin Rheumatol. 2017;36:119-124.
    PubMed     Text format     Abstract available


    Cytotherapy

  14. ESLAM RB, Croce K, Mangione FM, Musmann R, et al
    Persistence and proliferation of human mesenchymal stromal cells in the right ventricular myocardium after intracoronary injection in a large animal model of pulmonary hypertension.
    Cytotherapy. 2017 Apr 6. pii: S1465-3249(17)30426.
    PubMed     Text format     Abstract available


    Eur J Radiol

  15. JOHNS CS, Swift AJ, Hughes PJ, Ohno Y, et al
    Pulmonary MR angiography and perfusion imaging-A review of methods and applications.
    Eur J Radiol. 2017;86:361-370.
    PubMed     Text format     Abstract available


    Eur Respir Rev

  16. SITBON O, Gaine S
    Beyond a single pathway: combination therapy in pulmonary arterial hypertension.
    Eur Respir Rev. 2016;25:408-417.
    PubMed     Text format     Abstract available

  17. FARBER HW, Gin-Sing W
    Practical considerations for therapies targeting the prostacyclin pathway.
    Eur Respir Rev. 2016;25:418-430.
    PubMed     Text format     Abstract available

  18. RAINA A, Humbert M
    Risk assessment in pulmonary arterial hypertension.
    Eur Respir Rev. 2016;25:390-398.
    PubMed     Text format     Abstract available

  19. CLIFT P, Celermajer D
    Managing adult Fontan patients: where do we stand?
    Eur Respir Rev. 2016;25:438-450.
    PubMed     Text format     Abstract available

  20. HARARI S
    The revolution of pulmonary arterial hypertension.
    Eur Respir Rev. 2016;25:361-363.
    PubMed     Text format    

  21. CHELLADURAI P, Seeger W, Pullamsetti SS
    Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives.
    Eur Respir Rev. 2016;25:135-40.
    PubMed     Text format     Abstract available

  22. OLSSON KM, Channick R
    Pregnancy in pulmonary arterial hypertension.
    Eur Respir Rev. 2016;25:431-437.
    PubMed     Text format     Abstract available

  23. SIMONNEAU G, Hoeper MM, McLaughlin V, Rubin L, et al
    Future perspectives in pulmonary arterial hypertension.
    Eur Respir Rev. 2016;25:381-389.
    PubMed     Text format     Abstract available

  24. GRAARUP J, Ferrari P, Howard LS
    Patient engagement and self-management in pulmonary arterial hypertension.
    Eur Respir Rev. 2016;25:399-407.
    PubMed     Text format     Abstract available


    FEBS Open Bio

  25. CHEN Z, Wang Q
    Activation of PPARgamma by baicalin attenuates pulmonary hypertension in an infant rat model by suppressing HMGB1/RAGE signaling.
    FEBS Open Bio. 2017;7:477-484.
    PubMed     Text format     Abstract available


    G Ital Cardiol (Rome)

  26. CORREALE M, Brunetti ND, Di Biase M, Morandi F, et al
    [European guidelines on pulmonary hypertension].
    G Ital Cardiol (Rome). 2017;18:169.
    PubMed     Text format    


    Heart Vessels

  27. KO T, Hatano M, Nitta D, Muraoka H, et al
    A case of interferon-alpha-induced pulmonary arterial hypertension after living donor liver transplantation.
    Heart Vessels. 2016;31:1206-8.
    PubMed     Text format     Abstract available


    Histol Histopathol

  28. TAKEUCHI T, Sakao S, Kato F, Naito A, et al
    Pulmonary haemodynamics are correlated with intimal lesions in a rat model of severe PAH: attenuation of pulmonary vascular remodelling with ambrisentan.
    Histol Histopathol. 2016;31:1357-65.
    PubMed     Text format     Abstract available

  29. ZHENG Z, Yu S, Zhang W, Peng Y, et al
    Genistein attenuates monocrotaline-induced pulmonary arterial hypertension in rats by activating PI3K/Akt/eNOS signaling.
    Histol Histopathol. 2017;32:35-41.
    PubMed     Text format     Abstract available


    Int Immunopharmacol

  30. ZHAO H, Xue Y, Guo Y, Sun Y, et al
    Inhibition of endocan attenuates monocrotaline-induced connective tissue disease related pulmonary arterial hypertension.
    Int Immunopharmacol. 2017;42:115-121.
    PubMed     Text format     Abstract available


    Intern Med

  31. SUGAWARA E, Kato M, Hisada R, Oku K, et al
    Treatment of Vasodilator-resistant Mixed Connective Tissue Disease-associated Pulmonary Arterial Hypertension with Glucocorticoid and Cyclophosphamide.
    Intern Med. 2017;56:445-448.
    PubMed     Text format     Abstract available


    J Coll Physicians Surg Pak

  32. AHMED I, Hassan Nuri MM, Zakariyya AN, Ahmad SM, et al
    Correlation Between Doppler Echocardiography and Right Heart Catheterization Derived Pulmonary Artery Pressures: Impact of Right Atrial Pressures.
    J Coll Physicians Surg Pak. 2016;26:255-9.
    PubMed     Text format     Abstract available


    J Int Med Res

  33. HAN X, Zhang Y, Zhou Z, Zhang X, et al
    Hydroxysafflor yellow A improves established monocrotaline-induced pulmonary arterial hypertension in rats.
    J Int Med Res. 2016;44:569-84.
    PubMed     Text format     Abstract available


    J Pediatr Surg

  34. CARPENTIER E, Mur S, Aubry E, Pognon L, et al
    Safety and tolerability of subcutaneous treprostinil in newborns with congenital diaphragmatic hernia and life-threatening pulmonary hypertension.
    J Pediatr Surg. 2017 Mar 28. pii: S0022-3468(17)30207.
    PubMed     Text format     Abstract available

  35. TAKAHASHI T, Friedmacher F, Zimmer J, Puri P, et al
    Increased c-kit and stem cell factor expression in the pulmonary vasculature of nitrofen-induced congenital diaphragmatic hernia.
    J Pediatr Surg. 2016 Feb 11. pii: S0022-3468(16)00070.
    PubMed     Text format     Abstract available


    Oncotarget

  36. AMIRJANIANS M, Egemnazarov B, Sydykov A, Kojonazarov B, et al
    Chronic intratracheal application of the soluble guanylyl cyclase stimulator BAY 41-8543 ameliorates experimental pulmonary hypertension.
    Oncotarget. 2017 Mar 31. doi: 10.18632/oncotarget.16769.
    PubMed     Text format     Abstract available


    Paediatr Drugs

  37. ZISOWSKY J, Gehin M, Kusic-Pajic A, Krause A, et al
    Pediatric Development of Bosentan Facilitated by Modeling and Simulation.
    Paediatr Drugs. 2017;19:121-130.
    PubMed     Text format     Abstract available


    Pneumonol Alergol Pol

  38. SZTURMOWICZ M, Kacprzak A, Franczuk M, Burakowska B, et al
    Low DLCO in idiopathic pulmonary arterial hypertension - clinical correlates and prognostic significance.
    Pneumonol Alergol Pol. 2016;84:87-94.
    PubMed     Text format     Abstract available


    Poult Sci

  39. KAMELY M, Karimi Torshizi MA, Rahimi S
    Blood biochemistry, thyroid hormones, and performance in broilers with ascites caused by caffeine.
    Poult Sci. 2016;95:2673-2678.
    PubMed     Text format     Abstract available


    Rev Chil Pediatr

  40. KILCHEMMANN FUENTES C, Vallejos Vallejos C, Roman Navarro A
    [Cost effectiveness and budget impact analysis of inhaled nitric oxide in a neonatal unit from the perspective of the public health system].
    Rev Chil Pediatr. 2016;87:463-467.
    PubMed     Text format     Abstract available


    Rev Esp Cardiol (Engl Ed)

  41. DOMINGUEZ MANZANO P, Mendoza Soto A, Roman Barba V, Moreno Galdo A, et al
    Pulmonary Arterial Hypertension and Neonatal Arterial Switch Surgery for Correction of Transposition of the Great Arteries.
    Rev Esp Cardiol (Engl Ed). 2016;69:836-41.
    PubMed     Text format     Abstract available


    World J Gastroenterol

  42. SURANI SR, Mendez Y, Anjum H, Varon J, et al
    Pulmonary complications of hepatic diseases.
    World J Gastroenterol. 2016;22:6008-15.
    PubMed     Text format     Abstract available


    Zhongguo Dang Dai Er Ke Za Zhi

  43. GAO XY, Feng L, Qiu YF, Pan XN, et al
    [Application of humidified high-flow nasal cannula in neonates with meconium aspiration syndrome and pulmonary hypertension after extubation].
    Zhongguo Dang Dai Er Ke Za Zhi. 2017;19:393-397.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: